Clinical Trial Update: Dopamine in Orthostatic Tolerance [NA]

View source ↗

Summary

A clinical trial evaluating dopamine for orthostatic tolerance in Postural Tachycardia Syndrome was terminated. The sponsor listed is Vanderbilt University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Tachycardia Syndrome

Drugs mentioned

• Dopamine (dopamine)

Snippet

Sponsor: Vanderbilt University | Conditions: Postural Tachycardia Syndrome | NA | Status: TERMINATED